Abeona Therapeutics Inc. (ABEO) Financial Statements (2026 and earlier)

Company Profile

Business Address 6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:191,40498,10052,60052,50050,90095,000
Cash and cash equivalent78,43723,35714,47314,21732,93812,596
Short-term investments112,96774,36337,75337,93212,08682,438
Other undisclosed cash, cash equivalents, and short-term investments  3803743515,876(34)
Receivables6,7151,6522,4441883,000 
Inventory, net of allowances, customer advances and progress billings5,493     
Inventory5,493     
Other undisclosed current assets1,2941,1016934111,5012,742
Total current assets:204,906100,85355,73753,09955,40197,742
Noncurrent Assets
Operating lease, right-of-use asset3,9623,5524,4555,3319,4037,032
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization9,9214,4303,5335,74112,33911,322
Intangible asset, including goodwill, after accumulated amortization    1,3551,38433,966
Goodwill      32,466
Intangible asset, excluding goodwill, after accumulated amortization    1,3551,3841,500
Other noncurrent assets78196277   
Other undisclosed noncurrent assets    (1,312)1,0591,136
Total noncurrent assets:14,6648,0788,26511,11524,18553,456
TOTAL ASSETS:219,570108,93164,00264,21479,586151,198
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,3569,7747,8435,8029,9108,105
Accounts payable7,8893,4411,8581,8114,3254,695
Accrued liabilities8,4676,3335,9853,9915,5853,410
Deferred revenue     296296
Debt12,2225,9264,580  330
Other liabilities 2641204  
Due to related parties✕✕✕✕ 4,59931,515
Other undisclosed current liabilities9908239981,7731,8181,713
Total current liabilities:29,57016,58713,4227,77916,62341,959
Noncurrent Liabilities
Long-term debt and lease obligation7,81313,037  7,5606,688
Long-term debt, excluding current maturities7,81313,037   1,428
Liabilities, other than long-term debt4,0693,2624,40210,0174,028 
Deferred revenue      
Due to related parties✕✕✕✕4,1633,828 
Other liabilities     200 
Operating lease, liability4,0693,2624,4025,8547,5605,260
Other undisclosed noncurrent liabilities18,90232,01431,35219,657 (5,260)
Total noncurrent liabilities:30,78448,31335,75429,67411,5886,688
Total liabilities:60,35464,90049,17637,45328,21148,647
Equity
Equity, attributable to parent159,21644,03114,82626,76151,375102,551
Common stock5504572651771,472961
Additional paid in capital900,603856,824764,151722,049705,570672,304
Accumulated other comprehensive income (loss)1388(66)(129)(27)(10)
Accumulated deficit(742,075)(813,258)(749,524)(695,336)(655,640)(570,704)
Total equity:159,21644,03114,82626,76151,375102,551
TOTAL LIABILITIES AND EQUITY:219,570108,93164,00264,21479,586151,198

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues5,8204,2463,5001,4143,00010,000
Net investment income5,5564,2462,117431  
Cost of revenue
(Cost of Product and Service Sold)		(1,532)     
Gross profit:4,2884,2463,5001,4143,00010,000
Operating expenses(93,736)(64,211)(50,635)(52,329)(92,836)(91,420)
Other undisclosed operating income (loss) (4,246)    
Operating loss:(89,448)(64,211)(47,135)(50,915)(89,836)(81,420)
Nonoperating income4101,1942,943   
Interest and debt expense   (418)(736)(3,670)(4,115)
Loss from continuing operations before equity method investments, income taxes:(89,038)(63,017)(44,610)(51,651)(93,506)(85,535)
Other undisclosed income from continuing operations before income taxes160,321     
Income (loss) from continuing operations before income taxes:71,283(63,017)(44,610)(51,651)(93,506)(85,535)
Income tax expense(100)     
Income (loss) from continuing operations:71,183(63,017)(44,610)(51,651)(93,506)(85,535)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(93,506)(85,535)
Net income (loss):71,183(63,017)(44,610)(51,651)(93,506)(85,535)
Other undisclosed net income (loss) attributable to parent  (717)(9,578)11,9558,5701,301
Net income (loss) attributable to parent:71,183(63,734)(54,188)(39,696)(84,936)(84,234)
Preferred stock dividends and other adjustments    (3,782)  
Other undisclosed net income available to common stockholders, basic  34    
Net income (loss) available to common stockholders, basic:71,183(63,700)(54,188)(43,478)(84,936)(84,234)
Other undisclosed net income (loss) available to common stockholders, diluted(4,106)     
Net income (loss) available to common stockholders, diluted:67,077(63,700)(54,188)(43,478)(84,936)(84,234)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):71,183(63,017)(44,610)(51,651)(93,506)(85,535)
Other comprehensive income (loss)1307463(102)(17) 
Comprehensive income (loss):71,313(62,943)(44,547)(51,753)(93,523)(85,535)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (717)(9,578)8,1738,5701,291
Comprehensive income (loss), net of tax, attributable to parent:71,313(63,660)(54,125)(43,580)(84,953)(84,244)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: